Hormonal
Intensive lifestyle intervention (ILI) aimed at weight loss reduces the incidence of obesity-related cancers by 16% in adults with type 2 diabetes, although the result was not statistically significant due to insufficient statistical power.
For individuals with type 2 diabetes and obesity, engaging in a structured weight loss program involving calorie restriction (1,200-1,800 kcal/day), moderate exercise (175 mins/week), and behavioral counseling can significantly lower the risk of developing obesity-related cancers. While the statistical evidence in this specific trial was borderline due to sample size, the consistent trend toward reduced risk suggests that maintaining a healthy weight is a critical cancer prevention strategy for this population.
An ILI aimed at weight loss lowered incidence of obesity-related cancers by 16% in adults with overweight or obesity and type 2 diabetes. The study sample size likely lacked power to determine effect sizes of this magnitude and smaller.
Why this rating
High-quality randomized controlled trial design with long follow-up (median 11 years), but limited by lack of statistical significance and potential misclassification of cancer sites.
Source
Intensive Weight Loss Intervention and Cancer Risk in Adults with Type 2 Diabetes: Analysis of the Look AHEAD Randomized Clinical Trial
Hsin‐Chieh Yeh et al. · Obesity · 2020
DOI 10.1002/oby.22936
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →